These cheap stocks could see huge gains during a vaccine-driven economic rebound

There’s no doubt that the coronavirus economy has been terrible for value stocks. But with expectations growing that there will be effective COVID-19 vaccines late this year or sometime in 2021, it’s time to think about which stocks that have been hit so hard this year will soar as earnings expectations normalize.

Increasing earnings estimates tend to drive stock prices higher, and for slower-growing companies, rising estimates as recovery expectations solidify, and even P/E multiple expansion, can lead to significant gains for investors who are willing to go in now and wait. Patiently. Among the remaining 478 constituents of the S&P 500, here are the 30 that are the most cheaply priced against calendar 2022 consensus earnings estimates:Here’s the list again, this time with analysts’ ratings and price targets. Scroll the table at the bottom, to the right, to see all the data.

PhilipvanDoorn There is no vaccine.

PhilipvanDoorn Thoughts on the new tesla director ?

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

European stocks nudge higher after worst drubbing in three months amid second wave concernsEuropean stocks edged higher Tuesday after their worst one-day performance in more than three months, as the Continent faces tighter economic restrictions... CommSec It's about europoors start pumping stocks! Can't just rely on JPOWs printer all year!
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »